| Literature DB >> 22637476 |
Kana Namiki1, Hirofumi Matsunaga, Kento Yoshioka, Kensuke Tanaka, Kazuya Murata, Junji Ishida, Akira Sakairi, Jundal Kim, Naoki Tokuhara, Nobuhiko Shibakawa, Motohisa Shimizu, Yukinori Wada, Yasunori Tokunaga, Manabu Shigetomi, Masahiko Hagihara, Sadao Kimura, Tatsuhiko Sudo, Akiyoshi Fukamizu, Yoshitoshi Kasuya.
Abstract
One of the mitogen-activated protein kinases, p38, has been found to play a crucial role in various inflammatory responses. In this study, we analyzed the roles of p38α in multiple sclerosis, using an animal model, experimental autoimmune encephalomyelitis (EAE). p38α(+/-) mice (p38α(-/-) showed embryonic lethality) showed less severe neurological signs than WT mice. Adoptive transfer of lymph node cells (LNC) from sensitized WT mice with MOG(35-55) to naive WT-induced EAE was much more severe compared with the case using LNC from sensitized p38α(+/-) mice. Comprehensive analysis of cytokines from MOG(35-55)-challenged LNC by Western blot array revealed that production of IL-17 was significantly reduced by a single copy disruption of the p38α gene or a p38 inhibitor. Likewise, by a luciferase reporter assay, an electrophoresis mobility shift assay, and characterization of the relationship between p38 activity and IL-17 mRNA expression, we confirmed that p38 positively regulates transcription of the Il17 gene. Furthermore, oral administration of a highly specific p38α inhibitor (UR-5269) to WT mice at the onset of EAE markedly suppressed the progression of EAE compared with a vehicle group. These results suggest that p38α participates in the pathogenesis of EAE through IL-17 induction.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22637476 PMCID: PMC3397849 DOI: 10.1074/jbc.M111.338541
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157